A concise profile of the University of Maryland Medical System in Baltimore
PMOS, previously grouped with PCOS, affects about 1 in 8 women and involves insulin resistance and testosterone imbalance. Case studies show GLP-1 medications may improve symptoms and menstrual regularity, with trials underway. Diagnosis remains challenging and access to new treatments will depend on healthcare systems.